Tourmaline Bio Rings the Closing Bell

About This Event

Tourmaline Bio, Inc. (Tourmaline) (Nasdaq: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically improve the lives of patients with life-altering immune and inflammatory diseases, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Sandeep Kulkarni, Chief Executive Officer, rings the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore